Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Sun Hwa Kim, Tae Wook Kang, Kyunghee Lim, Hyun Sung Joh, Jiseok Kang, Dong Hyun Sinn

Clin Mol Hepatol. 2017;23(2):179-183. Published online April 28, 2017

DOI: https://doi.org/10.3350/cmh.2016.0027

View: 8460 Download: 108 Web of Science: 10 Crossref: 13

Soo Yeon Lee, Baek-hui Kim

Clin Mol Hepatol. 2017;23(1):91-94. Published online March 17, 2017

DOI: https://doi.org/10.3350/cmh.2017.0011

View: 8103 Download: 141 Web of Science: 15 Crossref: 15

Kyoung Doo Song, Woo Kyoung Jeong

Clin Mol Hepatol. 2015;21(2):187-191. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.187

View: 8497 Download: 116 Web of Science: 10 Crossref: 10

Won Jae Lee

Clin Mol Hepatol. 2008;14(1):113-115. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.113

View: 3755 Download: 15 Crossref: 2

Young Nyun Park,Chan Il Park

Clin Mol Hepatol. 2001;7(4):494-496. Published online January 1, 1970

View: 2418 Download: 15

1 |

Viewed By 5388	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5347	MAFLD: How is it different from NAFLD?
Viewed By 5235	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3913	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3880	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search